Protective association of the <i>HIF-1α</i> rs11549465 polymorphism with metabolic syndrome in people living with HIV on antiretroviral therapy.

In the 11-20-years category, the odds of MS were lower but did not reach statistical significance (OR 0.34, p = 0.131), while no difference was observed in participants with a duration of HIV infection >20 years (OR 1.00, p = 1.000) ( Figure 2A ).

also in 111,027 other papers